Consolidated income statement
Millions of euros |
Note |
2024 |
2023 |
Sales |
4 |
1,288.1 |
1,264.1 |
Cost of sales |
-976.0 |
-958.7 |
|
Gross profit |
312.1 |
305.4 |
|
Selling expenses |
-74.3 |
-74.1 |
|
Research and development costs |
-48.0 |
-45.6 |
|
General and administrative expenses |
-113.3 |
-103.2 |
|
Other gains and losses |
6 |
0.8 |
-5.2 |
Operating result |
77.3 |
77.3 |
|
Financial income |
7 |
11.5 |
6.4 |
Financial charges |
7 |
-22.7 |
-34.8 |
Results from joint ventures and associates, net of tax |
14 |
-3.6 |
-3.5 |
Result before taxes |
62.5 |
45.4 |
|
Income tax expense |
8 |
-16.6 |
-2.3 |
Result after taxes from continuing operations |
45.9 |
43.1 |
|
Result after taxes from discontinued operations |
9 |
146.3 |
29.8 |
Result after taxes |
192.2 |
72.9 |
|
Result attributable to non-controlling interests |
|||
Result attributable to equity holders of Corbion nv |
192.2 |
72.9 |
|
Per ordinary share in euros total operations |
10 |
||
Basic earnings |
3.29 |
1.23 |
|
Diluted earnings |
3.24 |
1.22 |
|
Per ordinary share in euros continuing operations |
10 |
||
Basic earnings |
0.79 |
0.73 |
|
Diluted earnings |
0.77 |
0.72 |